2022 Full Event Guide

View the Entire Speaker Faculty, Session Details, Partner Information, Pricing & Discounts

september brochure pic

Having trouble downloading the brochure? Let us know and we’ll email it to you instead

Top 5 Reasons to Attend:

  • Decipher the intricate mechanisms underlying dysregulated inflammasome signaling within the wider context of the immune system
  • Overcome limitations of preclinical models, identifying clinically meaningful biomarkers of inflammasome inhibition, and defining good clinical endpoints
  • Tame inflammation and achieving optimized safety profiles using the next frontier for inflammasome-targeted drugs including those targeting NLRP3 and novel targets
  • Delve into specific disease groups to demonstrate where inflammasome therapeutics will be most impactful